Drug Safety Matters dives into the fascinating field of pharmacogenomics and the implications it has for tailored treatments and safer prescribing practices.
Research / 03 August 2021
With multiple medicine use on the rise, a UK study has set out to gather evidence for safer practices to get patients off the drugs they no longer need.
Research / 16 June 2021
Check in with UMC’s head of pharmacovigilance science to catch up with her team’s current research priorities.
Research / 09 April 2021
Causality is a tricky business in pharmacovigilance. With limited numbers of adverse event reports, how are we supposed to draw conclusions about causal relationships?
Research / 17 November 2020